DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.76, $0.31 better than the analyst estimate of $0.45. Revenue for the quarter came in at $59.5 million versus the consensus estimate of $551.27 million.

GUIDANCE:

DexCom sees FY2021 revenue of $2.35-2.4 billion, versus the consensus of $2.34 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.